Purchase Order 75F40126P00183
- Not listed
- The Food and Drug Administration awarded a firm fixed price purchase order to Lonza Walkersville, Inc. for the purchase of a 4D Nucleofector instrument and accessories, with a contract ceiling value of $59,695.40. The solicitation was posted on August 19, 2019, with a due date of August 26, 2019, and the contract was awarded on August 29, 2019, with an ultimate completion date of September 3, 2024. This procurement was conducted as open competition with no set-aside designation. The work will be...
- The NIH Clinical Center awarded a $23,613.01 firm fixed-price purchase order to Lonza Walkersville, Inc. for procurement of a 4D-Nucleofector System. The contract, awarded on September 3, 2025, with completion targeted for September 2, 2026, represents an open competition award with no set-aside designation. Lonza Walkersville, a foreign-owned biological materials and laboratory equipment manufacturer based in Walkersville, Maryland, will perform the work at its local facility. The...
- The Food and Drug Administration awarded a purchase order to Precision Nanosystems US Inc. for a NanoAssemblr Ignite bench-top lipid nanoparticle assembler instrument system with a ceiling value of $119,600.58 on August 22, 2022. The order carries a total small business set-aside. Place of performance is South San Francisco, California. The firm fixed-price purchase order was issued under a solicitation posted June 27, 2022 with a due date of July 8, 2022, and carries an ultimate completion date...
- <p>The National Institute of Child Health and Human Development awarded a firm fixed-price purchase order to Lonza Walkersville, Inc. for a 4D-Nucleofector Core Unit and related parts in the amount of $19,129.25, with an award date of June 25, 2021 and ultimate completion date of September 30, 2021. Place of performance is Bethesda, Maryland. The order references quote 20133944/3 and carries no set-aside designation.</p>
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lonza Walkersville, Inc. for the delivery of Nucleofector units, a specialized piece of laboratory equipment used for transfecting cells. The $13,022 contract was awarded on November 6, 2013 with a completion date of November 7, 2013. The award was not set aside for any specific business type. Lonza Walkersville, Inc....
- The Food and Drug Administration awarded a purchase order to Illumina, Inc. for one whole genome sequencing instrument on June 25, 2026, at a fixed price of $53,442.90. The procurement was conducted on a sole-source basis under FAR Part 12 as a commercial product acquisition. The order specifies an Illumina MiSeq i100 sequencing system with training for up to three personnel and a one-year manufacturer's warranty covering parts, labor, and operational support. The system must support...
- The Department of Health and Human Services' Food and Drug Administration awarded a $749,396.58 firm fixed price purchase order to Pacific Biosciences of California, Inc. to deliver a Versatile Sequencing II System. The sequencing system must be capable of producing long reads between 8,000 to over 20,000 bases, running a minimum of eight multiplexed samples simultaneously, and accommodating a cell confinement structure with 100,000 to 150,000 zero-mode waveguide holes, as specified in the...
- Lonza Walkersville, Inc. was awarded a firm fixed-price BPA call valued at $24,179.40 for a PART AAF-1002B 4D Nucleofector Core Unit, FL1 by the National Institutes of Health Office of the Director. The award, issued on July 23, 2015, with an ultimate completion date of December 31, 2015, was made without a set-aside designation, indicating open competition. The equipment will be delivered to the NIH campus in Bethesda, Maryland. This procurement leverages Lonza Walkersville's existing $10...
- The Food and Drug Administration awarded a $5,340 firm fixed-price delivery order to Government Scientific Source Inc. for a Gene Pulser XCell Microbial System (RSVP 1137J) on August 25, 2017, with an ultimate completion date of August 24, 2018. This delivery order was executed under the General Services Administration's Scientific Equipment and Services Multiple Award Schedule (FSS-66), which enables federal agencies to procure specialized laboratory equipment and scientific instruments through...
- The Food and Drug Administration awarded a purchase order to Cell Microsystems Inc. for $52,550.00 on July 6, 2026, to procure a BioFlux 200+ flexible shear flow system under a Total Small Business set-aside. The equipment will be delivered to Durham, North Carolina and is intended for the FDA's Laboratory of Cellular Hematology to evaluate human platelets and red blood cells in physiological environments. The system must be new, capable of delivering shear flow rates from 0 to 200 dynes/cm²,...
The Food and Drug Administration awarded a purchase order to Lonza Walkersville, Inc. for a 4D nucleofection system valued at $24,329.00 on August 17, 2026, with a completion date of December 15, 2026. The system will be installed at FDA/CBER in Silver Spring, Maryland. The equipment is designed to deliver DNA, RNA, and proteins into cell lines (HEK293, CHO, Huh7) and human primary cells using conductive polymer electrodes, process 2104 to 1107 cells per reaction, achieve post-transfection cell viability up to 90 percent, and include factory-preprogrammed pulse protocols calibrated for primary human dendritic cells. The system is supplied as a turn-key solution with installation, training, and a one-year warranty. The procurement originated from FDA Sources Sought Notice 75F40126SSN134795, posted July 1, 2026, with a July 8, 2026 response deadline. The FDA targeted small business concerns under NAICS 334516 (Analytical Laboratory Instrument Manufacturing), though all interested parties were invited to respond.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Lonza 4D or equal nucleofection system | 75F40126SSN134795 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Pre-Solicitation 1/2 | 7/1/26, 11:09 AM | |
Lonza 4D or equal nucleofection system | 75F40126Q134795 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 2/2 | 7/26/26, 10:28 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 8/16/26 |